| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.8M | +12.1% | +57.6% |
| R&D Expense | $16.6M | +2.9% | +22.7% |
| SG&A Expense | $5.1M | +10.7% | +18.6% |
| Operating Income | -$10.9M | +1.9% | +0.7% |
| Pre-tax Income | -$9.2M | +9.8% | +4.3% |
| Income Tax | $0 | — | — |
| Net Income | -$9.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.5M | -6.1% | -20.8% |
| Accounts Receivable | $912K | — | — |
| Current Assets | $236.8M | +205.7% | +141.1% |
| Total Assets | $240.0M | +197.1% | +139.4% |
| Current Liabilities | $53.4M | +12.9% | +28.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.3M | — | — |
| Capital Expenditures | $42K | — | — |
| Investing Cash Flow | -$134.7M | — | — |
| Financing Cash Flow | $174.2M | — | — |
| Free Cash Flow | -$55.4M | — | — |
| +4.3% |
| EPS (Basic) | -$0.72 | +45.9% | +52.3% |
| EPS (Diluted) | -$0.72 | +45.9% | +52.3% |
| $57.3M |
| -8.6% |
| -22.8% |
| Stockholders' Equity | $182.7M | +909.4% | +602.6% |